Metastatic prostate cancer presenting as obstructive jaundice.

Area of Science:

• Oncology
• Gastroenterology
• Hepatology

Background:

• Metastatic prostate cancer typically follows established patterns of spread.
• Common bile duct obstruction is an infrequent complication of prostate cancer metastasis.
• Jaundice and abnormal liver function tests (LFTs) in metastatic cancer often indicate poor prognosis due to liver involvement.

Observation:

• This case report details a rare instance of prostate cancer metastasizing to obstruct the common bile duct.
• The patient presented with jaundice and abnormal LFTs secondary to extrahepatic biliary obstruction.
• This presentation differs from the more common scenario of intrahepatic metastases causing abnormal LFTs.

Findings:

• Extrahepatic bile duct obstruction by metastatic prostate cancer is an uncommon but significant clinical presentation.
• Abnormal LFTs due to biliary obstruction may indicate a different prognostic pathway than those caused by liver parenchymal metastases.
• Patients with biliary obstruction may have a more favorable outcome than initially suggested by abnormal LFTs alone.

Implications:

• Recognizing extrahepatic biliary obstruction as a cause of jaundice in prostate cancer is crucial for accurate prognostication.
• This case challenges the universal association of abnormal LFTs with poor survival in metastatic prostate cancer.
• Further research is warranted to differentiate prognostic indicators based on the location of metastatic disease and its impact on liver function.